Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer-Reference-Cited by-同舟云学术

Statement by the Kommission OVAR of the AGO Study Group on the Use of HIPEC (Hyperthermic Intraperitoneal Chemotherapy) to Treat Primary and Recurrent Ovarian Cancer

Published:2013-04-04 Issue:03 Volume:73 Page:221-223
ISSN:0016-5751
Container-title:Geburtshilfe und Frauenheilkunde
language:de
Short-container-title:Geburtsh Frauenheilk

Author:

Harter P.¹,Mahner S.²,Hilpert F.³,Runnebaum I.⁴,Ortmann O.⁵,Mustea A.⁶,Sehouli J.⁷,du Bois A.¹,Wagner U.⁸,

Affiliation:

1. Kliniken-Essen-Mitte, Essen

2. Universitätsklinikum Hamburg-Eppendorf, Hamburg

3. Universitätsklinikum Schleswig Holstein, Campus Kiel, Kiel

4. Universitätsklinikum Jena, Jena

5. Universitätsklinikum Regensburg, Regensburg

6. Universitätsklinikum Greifswald, Greifswald

7. Universitätsmedizin Berlin Charite, Berlin

8. Universitätsklinikum Marburg, Marburg

Publisher

Georg Thieme Verlag KG

Subject

Maternity and Midwifery,Obstetrics and Gynecology

Link

http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0032-1328320.pdf

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Statement of the AGO Kommission Ovar, AGO Study Group, NOGGO, AGO Austria, Swiss AGO, BGOG, CEEGOG, GEICO, and SFOG regarding the use of hyperthermic intraperitoneal chemotherapy (HIPEC) in epithelial ovarian cancer;Bulletin du Cancer;2023-03

2. Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An Overview of the Molecular and Cellular Mechanisms of Actions and Effects on Epithelial Ovarian Cancers;International Journal of Molecular Sciences;2022-09-03

3. Is there a role for HIPEC in ovarian cancer?;Archives of Gynecology and Obstetrics;2018-09-20

4. The use of PIPAC (pressurized intraperitoneal aerosol chemotherapy) in gynecological oncology: a statement by the German “Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR)”, the Swiss and Austrian AGO, and the North-Eastern German Society of Gynaecologic Oncology;Archives of Gynecology and Obstetrics;2018-01-22

5. Aktuelle Behandlungsstrategien für das fortgeschrittene Ovarialkarzinom;gynäkologie + geburtshilfe;2016-10